Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation

v3.19.3.a.u2
Stock-Based Compensation
12 Months Ended
Dec. 31, 2019
Share-based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
2013 Equity Incentive Plan
In July 2013, the Board of Directors approved the 2013 Plan. In March 2015, the Board of Directors authorized an additional 3,000,000 shares reserved for issuance under the 2013 Plan. An aggregate of 4,500,000 shares of common stock are reserved for issuance under the 2013 Plan plus (i) any shares that were reserved but not issued under the plan that was previously in place, and (ii) any shares subject to stock options or similar awards granted under the plan that was previously in place that expire or otherwise terminate without having been exercised in full and shares issued that are forfeited to or repurchased by the Company, with the maximum number
of shares to be added to the 2013 Plan pursuant to clauses (i) and (ii) equal to 8,044,829 shares. Stock options granted to employees generally have a maximum term of ten-years and vest over a four-year period from the date of grant; 25% vest at the end of one year, and 75% vest monthly over the remaining three years. The options may include provisions permitting exercise of the option prior to full vesting. Any unvested shares shall be subject to repurchase by the Company at the original exercise price of the option in the event of a termination of an optionee’s employment prior to vesting. All the remaining shares that were available for future grants under the 2013 Plan were transferred to the 2015 Equity Incentive Plan (“2015 Plan”) at the inception of the 2015 Plan. As of December 31, 2019, the Company had not granted restricted stock or other equity awards (other than options) under the 2013 Plan.
2014 Equity Incentive Plan
In August 2014, the Board approved the 2014 Equity Incentive Plan (“2014 Plan”). An aggregate of 947,342 shares of common stock are reserved for issuance under the 2014 Plan. The 2014 Plan was adopted to accommodate a broader transaction with a sales entity and to allow for similar transactions in the future. In July 2015, the Board approved an increase in the number of shares of common stock reserved to 1,197,342. As of July 2015, the Company granted all 1,197,342 restricted stock units (“RSUs”) available under the 2014 Plan.
2015 Equity Incentive Plan
In July 2015, the Board approved the 2015 Plan. An aggregate of 11,400,000 shares of common stock are reserved for issuance under the 2015 Plan plus (i) any shares that were reserved but not issued under the 2013 Plan at the inception of the 2015 Plan, and (ii) any shares subject to stock options or similar awards granted under the 2008 Plan, 2013 Plan and 2014 Plan that expire or otherwise terminate without having been exercised in full and shares issued that are forfeited to or repurchased by the Company, with the maximum number of shares to be added to the 2015 Plan pursuant to clauses (i) and (ii) equal to 15,439,334 shares. The 2015 Plan provides for annual automatic increases on January 1 to the shares reserved for issuance. The automatic increase of the number of shares available for issuance under the 2015 Plan is equal to the least of 10 million shares, 4% of the outstanding shares of common stock as of the last day of our immediately preceding fiscal year or such other amount as the Board of Directors may determine. In 2019 and 2018, the Board of Directors authorized an additional 4,525,946 and 4,294,010 shares reserved for issuance under the 2015 Plan, respectively. Stock options granted to employees generally have a maximum term of ten-years and vest over a four-year period from the date of grant; 25% vest at the end of one year, and 75% vest monthly over the remaining three years. The options may include provisions permitting exercise of the option prior to full vesting. Any unvested shares shall be subject to repurchase by the Company at the original exercise price of the option in the event of a termination of an optionee’s employment prior to vesting. RSUs granted to employees generally vest over a four-year period from the date of grant; 25% vest at the end of one year, and 75% vest quarterly over the remaining three years.
Stock Options
The following table summarizes the activity for all stock options under all of the Company’s equity incentive plans for the years ended December 31, 2019 and 2018 (shares and aggregate intrinsic value in thousands):
 
 
Number of Options
 
Weighted
Average
Exercise Price
 
Weighted
Average
Remaining
Contractual Life
 
Aggregate
Intrinsic
Value
Outstanding at December 31, 2017
 
16,268

 
$
5.70

 
7.41
 
$
14,832

Granted
 
1,529

 
8.63

 
 
 
 
Exercised
 
(3,271
)
 
5.23

 
 
 
 
Cancelled
 
(936
)
 
6.63

 

 
 
Outstanding at December 31, 2018
 
13,590

 
6.07

 
6.63
 
66,462

Granted
 
1,362

 
15.44

 
 
 
 
Exercised
 
(3,625
)
 
5.48

 
 
 
 
Cancelled
 
(543
)
 
7.62

 
 
 
 
Outstanding at December 31, 2019
 
10,784

 
$
7.38

 
6.52
 
$
71,745

Options vested and exercisable at December 31, 2019
 
7,245

 
$
6.18

 
5.72
 
$
55,426

Options vested and expected to vest at December 31, 2019
 
10,784

 
$
7.38

 
6.52
 
$
71,745


There were 276,660 unvested exercisable shares as of the year ended December 31, 2018, which are subject to a repurchase option held by the Company at the original exercise price. These exercisable but unvested shares had a weighted average remaining vesting period of less than a year. There was no exercise of unvested options in the years ended December 31, 2019 and 2018. These options became fully vested during the year ended December 31, 2019.
The weighted-average grant-date fair value of stock options granted during the year ended December 31, 2019, 2018 and 2017 were $8.27, $4.21 and $2.57 per share, respectively. The total intrinsic value of the options exercised during the year ended December 31, 2019, 2018 and 2017 was $37.8 million, $21.4 million and $2.3 million, respectively. The aggregate intrinsic value is the difference of the current fair value of the stock and the exercise price for in-the-money stock options. The total fair value of options vested during the year ended December 31, 2019, 2018 and 2017 was $9.5 million, $8.8 million and $7.5 million, respectively. 
The Company estimates the fair value of stock-based awards on their grant date using the Black-Scholes option-pricing model. The Company estimates the fair value using a single-option approach and amortizes the fair value on a straight-line basis for options expected to vest. All options are amortized over the requisite service periods of the awards, which are generally the vesting periods.
The Company estimated the fair value of stock options with the following assumptions:
 
 
Year Ended December 31,
 
 
2019
 
2018
 
2017
Risk-free interest rate
 
1.70% - 2.59%

 
2.72% - 2.92%

 
1.88% - 2.22%

Volatility
 
52.9% - 55.07%

 
44.87% - 54.61%

 
45.95% - 50.52%

Expected term (in years)
 
6.10 - 6.12

 
6.09 - 6.11

 
5.94 - 6.08

Expected dividend yield
 
0.00
%
 
0.00
%
 
0.00
%

The expected term assumptions were determined based on the average vesting terms and contractual lives of the options. The risk-free interest rate is based on the rate for a U.S. Treasury zero-coupon issue with a term that approximates the expected life of the option grant. For stock options granted in the year ended December 31, 2019, 2018 and 2017, the Company considered the volatility data of a group of publicly traded peer companies in its industry. The Company accounts for forfeitures as they occur and, as such, reverses compensation cost previously
recognized in the period the award is forfeited, for an award that is forfeited before completion of the requisite service period.
Restricted Stock Units
In 2014, the Company granted a total of 947,342 RSUs subject to certain performance targets to a third party partner. As of December 31, 2017, 350,000 outstanding RSUs had a performance feature that is required to be satisfied before the option is vested. In March 2018, the Company amended the terms of all of these RSUs, such that the RSUs are deemed earned subject to a clawback provision that requires the holder of the RSUs to either forfeit all the RSUs or pay the Company repayment value for all RSUs that are not forfeited if the third party breaches the exclusivity provision of the parties’ commercial agreement. The exclusivity clawback provision for all of the RSUs expired in September 2019.
The performance-based provision is considered substantive. As a result, the Company recognizes expense once the performance targets are met. The first performance target was met in 2015. The Company recognized $3.5 million and $0.8 million compensation expense in the years ended December 31, 2018 and 2017 upon certain performance targets being met.
The following table summarizes the activity for all RSUs under all of the Company’s equity incentive plans for the years ended December 31, 2019 and 2018 (shares in thousands):
 
 
Shares
 
Weighted
Average Grant
Date Fair
Value
Unvested balance at December 31, 2017
 
5,330

 
$
5.82

Granted
 
2,019

 
8.75

Issued
 
(1,720
)
 
6.36

Cancelled / forfeited
 
(1,447
)
 
5.75

Unvested balance at December 31, 2018
 
4,182

 
7.05

Granted
 
2,258

 
15.25

Issued
 
(1,104
)
 
6.83

Cancelled / forfeited
 
(1,393
)
 
8.14

Unvested balance at December 31, 2019
 
3,943

 
$
11.42


Employee Stock Purchase Plan
Under the Company's 2015 Employee Stock Purchase Plan (“ESPP”) (as amended in May 2017), eligible employees are offered shares bi-annually through a 24 month offering period which encompasses four six-month purchase periods. Each purchase period begins on the first trading day on or after May 15 and November 15 of each year. Employees may purchase a limited number of shares of the Company’s common stock via regular payroll deductions at a discount of 15% of the lower of the fair market value of the Company’s common stock on the first trading date of each offering period or on the exercise date. Employees may deduct up to 15% of payroll, with a cap of $25,000 of fair market value of shares in any calendar year and 10,000 shares per employee per purchase period. Under the ESPP, 1,000,000 shares of the Company’s common stock have been reserved for issuance to eligible employees. The ESPP provides for an automatic increase of the number of shares available for issuance under the ESPP on the first day of each fiscal year beginning on January 1, 2016, equal to the least of 5 million shares, 2% of the outstanding shares of our common stock on the last day of the immediately preceding fiscal year, or such other amount as may be determined by the Board of Directors. In 2019 and 2018, the Board of Directors authorized an additional 2,262,973 and 2,147,005 shares, respectively, reserved for issuance under the ESPP.
Stock-Based Compensation Expense
The Company recognized stock-based compensation expense, including ESPP expenses, in the consolidated statements of operations as follows (in thousands): 
 
 
Year Ended December 31,
 
 
2019
 
2018
 
2017
Cost of customer agreements and incentives
 
$
2,434

 
$
2,568

 
$
2,299

Cost of solar energy systems and product sales
 
844

 
718

 
609

Sales and marketing
 
5,162

 
7,191

 
5,196

Research and development
 
1,439

 
1,253

 
836

General and administration
 
16,427

 
16,126

 
13,102

Total
 
$
26,306

 
$
27,856

 
$
22,042


As of December 31, 2019 and 2018, total unrecognized compensation cost related to outstanding stock options and RSUs was $30.0 million and $40.0 million, respectively, which are expected to be recognized over a weighted-average period of 2.3 years.
In August 2017, the Company entered into an agreement with an affiliate ("Contractor") of Comcast Corporation ("Comcast") whereby Contractor will receive lead or sales fees for new customers it brings to the Company over a 40-month term. Comcast may also earn a warrant to purchase up to 11,793,355 shares of the Company's outstanding common stock, at an exercise price of $0.01 per warrant share. The warrant initially vests 50.05% when both (i) Contractor has earned a lead or sales fee with respect to 30,000 of installed solar energy systems, and (ii) Contractor or its affiliates have spent at least $10.0 million in marketing and sales in connection with the agreement. Thereafter, the warrant will vest in five additional increments for each additional 6,000 installed solar energy systems. On November 7, 2018 the warrant vesting schedule was modified so that it will initially vest either (i) as to 10.0% if Contractor has earned a lead or sales fee with respect to 6,000 of installed solar energy systems by September 30, 2019 or (ii) as to 13.3% if Contractor has earned a lead or sales fee with respect to 8,000 of installed solar energy systems by December 31, 2019, provided that, in either case, Contractor or its affiliates have spent at least $25.0 million in marketing and sales in connection with the agreement.  Thereafter, the warrant will vest in additional 8.3% increments for each additional 5,000 installed solar energy systems.  The initial vesting conditions were not met by December 31, 2019, as a result, the warrant expired unvested.
401(k) Plan
The Company's 401(k) Plan is a deferred salary arrangement under Section 401(k) of the Internal Revenue Code. Under the 401(k) Plan, participating U.S. employees may defer a portion of their pre-tax earnings, up to the IRS annual contribution limit ($19,000 for calendar year 2019). Effective January 1, 2018, the Company matches 100% of the first 1% and 50% of the next 5% of each employee's contributions. The Company recognized expense of $8.5 million and $7.0 million in the years ended December 31, 2019 and 2018, respectively.